E-LIB Suche - Ergebnisse für: Hashmi, Hamza

1

Idecabtagene Vicleucel (ide-cel) Chimeric Antigen Receptor ..:

Fortuna, Gliceida Maria Galarza ; Sidana, Surbhi ; Hovanky, Vanna...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S381-S382 , 2024

Link: https://doi.org/10.1016/..

2

Impact of age, obesity, and renal impairment on outcomes af..:

Gaffney, Kelly J ; Bakos, Jonathan K. ; Velayati, Arash...
Journal of Oncology Pharmacy Practice. , 2024

Link: https://doi.org/10.1177/..

3

Outcomes of Large B-Cell Lymphoma (LBCL) Patients with Seco..:

Hashmi, Hamza ; Epperla, Narendranath ; Ahn, Kwang...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S42 , 2024

Link: https://doi.org/10.1016/..

4

A Multicenter Experience: Duration of Mandatory CRS and Ica..:

Wesson, William ; Dima, Danai ; Davis, James...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S207-S208 , 2024

Link: https://doi.org/10.1016/..

5

A comparative review of Aphexda and Mozobil for mobilizatio..:

Dietz, Lauren ; Marini, Jessica ; Hashmi, Hamza.
Journal of Oncology Pharmacy Practice. , 2024

Link: https://doi.org/10.1177/..

6

'Fast but Not so Furious': A Condensed but Safe and Cost-Ef..:

Graf, Kevin Chandler ; Davis, James A ; Cendagorta, Alyssa M...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S381 , 2024

Link: https://doi.org/10.1016/..

7

TACTUM: Trends in Access to Cellular Therapies in Multiple ..:

Atallah, Rawan ; Ahmed, Nausheen ; Ayoobkhan, Fathima...
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

8

Efficacy and Safety of Idecabtagene Vicleucel (ide-cel) in ..:

Dima, Danai ; Rashid, Aliya ; Davis, James...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S205-S206 , 2024

Link: https://doi.org/10.1016/..

9

ASTCT Committee on Practice Guidelines Survey on Evaluation..:

Hashmi, Hamza ; Kumar, Ambuj ; Kharfan-Dabaja, Mohamed A....
Transplantation and Cellular Therapy. , 2024

Link: https://doi.org/10.1016/..

10

Safety and Efficacy of Teclistamab in Patients with Relapse..:

Dima, Danai ; Davis, James A. ; Ahmed, Nausheen...
Transplantation and Cellular Therapy. 30 (2024) 3 - p. 308.e1-308.e13 , 2024

Link: https://doi.org/10.1016/..

11

Outcomes of BCMA-Directed Chimeric Antigen Receptor T-Cell ..:

Dima, Danai ; Davis, James ; Ahmed, Nausheen...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S384-S385 , 2024

Link: https://doi.org/10.1016/..

12

Racial and ethnic differences in clinical outcomes among pa..:

Peres, Lauren C. ; Oswald, Laura B. ; Dillard, Christen M....
Blood Advances. 8 (2024) 1 - p. 251-259 , 2024

Link: https://doi.org/10.1182/..

13

Efficacy and safety of idecabtagene vicleucel in patients w..:

Dima, Danai ; Rashid, Aliya ; Davis, James A....
British Journal of Haematology. 204 (2024) 4 - p. 1293-1299 , 2024

Link: https://doi.org/10.1111/..

14

Safety and Efficacy of Teclistamab in Patients with Relapse..:

Dima, Danai ; Davis, James ; Ahmed, Nausheen...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S384 , 2024

Link: https://doi.org/10.1016/..

15

The TACTUM23 Study: Access to Cellular Therapies in Multipl..:

Atallah, Rawan ; Saif, Md Saiful Islam ; Danai, Dima...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S375-S376 , 2024

Link: https://doi.org/10.1016/..